A Form 4 filed on August 14, 2026 discloses that Paul J. Evans, Executive Vice President, CFO and Treasurer of Pitney Bowes Inc /DE/ (NYSE:PBI), reported two transactions in common stock and one derivative security transaction dated August 13, 2026.
Renat Tukanov, Chief Technology Officer of Freedom Holding Corp. (NASDAQ:FRHC), filed a Form 4 on August 14, 2026, disclosing a sale of common stock executed on August 13, 2026.
Mark James King, Executive Chairman and Interim CEO of Jack in the Box Inc (NASDAQ:JACK), filed a Form 4 on August 14, 2026, disclosing the disposition of 5,647 shares of common stock to satisfy a tax withholding obligation upon the vesting of restricted stock …
A Form 4 filed on August 14, 2026, reports that Teh Ban Seng, Executive Vice President and Chief Commercial Officer of Seagate Technology Holdings plc (NASDAQ:STX), exercised stock options and sold ordinary shares on August 13, 2026.
A Form 4 filed on August 14, 2026 reports that John P. Skenesky, VP and Division Manager at McGrath RentCorp (NASDAQ:MGRC), disposed of 6,077 shares of common stock on August 12, 2026 through a diversification election under the company's Employee Stock Ownership and 401(k) …
Brian Lorig, Executive Vice President of KLA Global Services at KLA Corp, filed a statement of changes in beneficial ownership on August 14, 2026, reporting a sale of common stock executed on August 13, 2026.
Ryan J. Watts, President and CEO of Denali Therapeutics Inc. (NASDAQ:DNLI), filed a Form 4 on August 14, 2026, reporting a charitable transfer of 32,220 shares of common stock on August 12, 2026.
Alpana Wegner, Chief Financial Officer of Waystar Holding Corp. (NASDAQ:WAY), filed a Form 4 on August 14, 2026, disclosing the acquisition of 162,112 restricted stock units granted on July 24, 2026, at a price of $0.
A Form 4 filed with the SEC on August 14, 2026 discloses that Robert J. Chersi, a director of Bausch & Lomb Corp (NYSE:BLCO), acquired 11,776 restricted share units on August 12, 2026 at no cost under the company's 2022 Omnibus Incentive Plan.
Joaquin Duato, CEO and Chairman of the Board of Johnson & Johnson (NYSE:JNJ), filed a Form 4 on August 14, 2026, reporting stock option exercises and open-market sales of common stock transacted on August 13, 2026.